Tucotuzumab

Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM) . Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule[1].

Product Specifications

CAS Number

[339986-90-2]

UNSPSC

12352203

Target

Interleukin Related

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tucotuzumab.html

Purity

Solubility

10 mM in DMSO

Smiles

[Tucotuzumab]

Molecular Weight

(144.34 kDa)

References & Citations

[1]Erik E Johnson, et al. Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res. 2009 Aug 1;15 (15) :4875-84.